跳至主要内容
临床试验/CTRI/2024/08/072874
CTRI/2024/08/072874尚未招募2 期

A clinical study on kampavata with special reference to Parkinsons disease and its management with indigenous drug

Dr Neha Tiwari1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年8月28日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
To prevent signs and symptoms of Parkinsons disease in patients

研究概览

简要总结

This study a single blind randomized controlled trial of 3 months duration to compare efficacy of indigenous drug and levodopa in patients suffering from Kampavata with special reference to Parkinsons disease. The primary outcome is to prevent Parkinsons disease in patients and secondary outcome is to reduce tremor rigidity bradykinesia and postural disturbance in patients.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patient having the clinical sign and symptoms of Parkinsons disease.

排除标准

  • Patient aged below 18years and above 80years Patient having heart diseases Malignancies Hypothyroidism Uncontrolled Hypertension and Diabetes Mellitus Cerebrovascular accidents Alzheimers disease.

结局指标

主要结局

To prevent signs and symptoms of Parkinsons disease in patients

时间窗: 3months

次要结局

  • To reduce tremor rigidity bradykinesia postural disturbance in patients(3months)

研究者

发起方
Dr Neha Tiwari
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Neha Tiwari

Gopabandhu Ayurveda Mahavidyalaya Puri

研究点 (1)

Loading locations...

相似试验